Published in J Clin Oncol on April 15, 2003
Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol (2005) 7.57
Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol (2014) 3.12
Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract (2010) 2.93
Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med (2009) 2.70
The quality oncology practice initiative: assessing and improving care within the medical oncology practice. J Oncol Pract (2006) 2.40
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med (2009) 2.36
Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials (2008) 2.29
The organization of multidisciplinary care teams: modeling internal and external influences on cancer care quality. J Natl Cancer Inst Monogr (2010) 2.26
The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr (2010) 2.25
Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol (2011) 2.16
Cause of death in older men after the diagnosis of prostate cancer. J Am Geriatr Soc (2008) 2.01
Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer (2010) 1.85
Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract (2010) 1.85
Breast cancer survivors' perceptions of survivorship care options. J Clin Oncol (2011) 1.72
Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer. J Natl Cancer Inst (2010) 1.63
Cancer survivorship: a challenge for primary care physicians. Br J Gen Pract (2005) 1.40
Preventive care in prostate cancer patients: following diagnosis and for five-year survivors. J Cancer Surviv (2011) 1.38
Multilevel factors affecting quality: examples from the cancer care continuum. J Natl Cancer Inst Monogr (2012) 1.37
Cancer survivorship: challenges and changing paradigms. J Urol (2008) 1.36
Do survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract (2011) 1.34
Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol (2013) 1.32
Providing care for cancer survivors in integrated health care delivery systems: practices, challenges, and research opportunities. J Oncol Pract (2012) 1.31
The role of poverty rate and racial distribution in the geographic clustering of breast cancer survival among older women: a geographic and multilevel analysis. Am J Epidemiol (2008) 1.28
Cancer screening and preventative care among long-term cancer survivors in the United Kingdom. Br J Cancer (2010) 1.22
Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? J Oncol Pract (2009) 1.18
Breast, colorectal and prostate cancer screening for cancer survivors and non-cancer patients in community practices. J Gen Intern Med (2009) 1.16
Enhancement of identifying cancer specialists through the linkage of Medicare claims to additional sources of physician specialty. Health Serv Res (2008) 1.13
Cancer survivorship issues: life after treatment and implications for an aging population. J Clin Oncol (2014) 1.12
Caring for survivors of breast cancer: perspective of the primary care physician. Curr Oncol (2011) 1.11
Cancer survivorship care: exploring the role of the general internist. J Gen Intern Med (2009) 1.06
Decline in physical functioning in first 2 years after breast cancer diagnosis predicts 10-year survival in older women. J Cancer Surviv (2012) 0.99
Problems in transition and quality of care: perspectives of breast cancer survivors. Support Care Cancer (2010) 0.99
Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship. BMC Med Inform Decis Mak (2010) 0.98
Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer (2006) 0.97
Impact of survivorship-based research on defining clinical care guidelines. Cancer Epidemiol Biomarkers Prev (2011) 0.97
Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer. J Gen Intern Med (2013) 0.95
Access to preventive health care for cancer survivors. Am J Prev Med (2013) 0.94
Influence of primary care on breast cancer outcomes among Medicare beneficiaries. Ann Fam Med (2012) 0.94
Cancer screening practices of cancer survivors: population-based, longitudinal study. Can Fam Physician (2012) 0.93
Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis. J Cancer Surviv (2013) 0.93
Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med (2010) 0.93
Receipt of general medical care by colorectal cancer patients: a longitudinal study. J Am Board Fam Med (2011) 0.93
An international review of the patterns and determinants of health service utilisation by adult cancer survivors. BMC Health Serv Res (2012) 0.92
Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol (2009) 0.92
Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol (2013) 0.92
Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant (2010) 0.90
Area-level poverty is associated with greater risk of ambulatory-care-sensitive hospitalizations in older breast cancer survivors. J Am Geriatr Soc (2008) 0.89
Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01. J Clin Oncol (2010) 0.89
Antihypertensive medication adherence in cancer survivors and its affecting factors: results of a Korean population-based study. Support Care Cancer (2010) 0.89
Mode of primary cancer detection as an indicator of screening practice for second primary cancer in cancer survivors: a nationwide survey in Korea. BMC Cancer (2012) 0.88
Survivorship navigation outcome measures: a report from the ACS patient navigation working group on survivorship navigation. Cancer (2011) 0.88
The impact of primary care physicians on follow-up care of underserved breast cancer survivors. J Am Board Fam Med (2013) 0.87
Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv (2013) 0.87
Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv (2013) 0.86
Quality of care for chronic diseases in a British cohort of long-term cancer survivors. Ann Fam Med (2010) 0.86
The effect of care setting in the delivery of high-value colon cancer care. Cancer (2014) 0.86
Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901. J Cancer Surviv (2014) 0.85
Prevalence, predictors, and patient outcomes associated with physician co-management: findings from the Los Angeles Women's Health Study. Health Serv Res (2011) 0.85
Comorbid condition care quality in cancer survivors: role of primary care and specialty providers and care coordination. J Cancer Surviv (2015) 0.85
Prospective study of factors predicting adherence to surveillance mammography in women treated for breast cancer. J Clin Oncol (2012) 0.85
It's who you know: patient-sharing, quality, and costs of cancer survivorship care. J Cancer Surviv (2014) 0.83
Racial/Ethnic disparities in health care receipt among male cancer survivors. Am J Public Health (2013) 0.83
Physician visits and preventive care among Asian American and Pacific Islander long-term survivors of colorectal cancer, USA, 1996-2006. J Cancer Surviv (2013) 0.81
Adjuvant Radiation and Outcomes After Breast Conserving Surgery in Publicly Insured Patients. J Geriatr Oncol (2012) 0.81
Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia. Curr Oncol (2014) 0.80
Efficacy of an educational material on second primary cancer screening practice for cancer survivors: a randomized controlled trial. PLoS One (2012) 0.80
Disparities in barriers to follow-up care between African American and White breast cancer survivors. Support Care Cancer (2015) 0.79
Follow-up care experiences and perceived quality of care among long-term survivors of breast, prostate, colorectal, and gynecologic cancers. J Oncol Pract (2014) 0.79
Breast cancer survivorship symptom management: current perspective and future development. Breast Cancer Manag (2013) 0.79
Follow-up after treatment for breast cancer: Practical guide to survivorship care for family physicians. Can Fam Physician (2016) 0.79
How Beneficial is Follow-Up Mammography in Elderly Breast Cancer Survivors? Ann Surg Oncol (2016) 0.78
Memory and cancer: a review of the literature. Arch Psychiatr Nurs (2014) 0.78
Medicaid expansion and access to care among cancer survivors: a baseline overview. J Cancer Surviv (2015) 0.77
Models of care for early-stage breast cancer in Canada. Curr Oncol (2011) 0.77
Coupling of prostate and thyroid cancer diagnoses in the United States. Ann Surg Oncol (2014) 0.77
Patterns of bone density evaluation in a community population treated with aromatase inhibitors. Breast Cancer Res Treat (2012) 0.77
Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv (2014) 0.77
Skeletal manifestations of treatment of breast cancer. Curr Osteoporos Rep (2013) 0.77
Primary Care Provider Evaluation of Cancer Survivorship Care Plans Developed for Patients in their Practice. J Gen Pract (Los Angel) (2014) 0.76
A head and neck cancer intervention for use in survivorship clinics: a protocol for a feasibility study. Pilot Feasibility Stud (2016) 0.75
Moving survivorship care plans forward: focus on care coordination. Cancer Med (2016) 0.75
Oncologists' Experience with Patients with Second Primary Cancer and the Attitudes toward Second Primary Cancer Screening: A Nationwide Survey. Cancer Res Treat (2015) 0.75
Annual surveillance mammography after early-stage breast cancer and breast cancer mortality. Curr Oncol (2016) 0.75
Diabetes management before and after cancer diagnosis: missed opportunity. Ann Transl Med (2015) 0.75
Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med (2016) 0.75
Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey. PLoS One (2014) 0.75
One-Year Experience Managing a Cancer Survivorship Clinic Using a Shared-Care Model for Gastric Cancer Survivors in Korea. J Korean Med Sci (2016) 0.75
Cancer survivorship care for the general internist: have we paved the way for a smoother transition? J Gen Intern Med (2009) 0.75
Cancer screening of long-term cancer survivors. J Am Board Fam Med (2012) 0.75
Who Treats Patients with Diabetes and Compensated Cirrhosis. PLoS One (2016) 0.75
Periodontal health, perceived oral health, and dental care utilization of breast cancer survivors. J Public Health Dent (2015) 0.75
Gynecologic care for breast cancer survivors: assisting in the transition to wellness. Am J Obstet Gynecol (2011) 0.75
Breast and prostate cancer survivors' experiences of patient-centered cancer follow-up care from primary care physicians and oncologists. J Cancer Surviv (2016) 0.75
Racial disparities in the utilization of preventive health services among older women with early-stage endometrial cancer enrolled in Medicare. Cancer Med (2017) 0.75
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol (2009) 9.39
HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med (2007) 9.34
American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol (2005) 8.56
Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. N Engl J Med (2014) 6.76
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol (2004) 6.59
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol (2013) 6.56
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA (2006) 6.45
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol (2010) 6.39
Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med (2009) 5.68
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol (2010) 5.50
Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med (2014) 5.18
Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet (2004) 4.99
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol (2003) 4.95
Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer. J Clin Oncol (2010) 4.94
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2014) 4.61
Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol (2003) 4.50
American Society of Clinical Oncology Technology Assessment: chemotherapy sensitivity and resistance assays. J Clin Oncol (2004) 4.48
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer (2003) 4.47
CNS metastases in breast cancer. J Clin Oncol (2004) 4.42
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24
Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst (2002) 4.16
Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol (2004) 4.03
Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J Clin Oncol (2011) 3.96
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ (2014) 3.90
Informing clinical trial participants about study results. JAMA (2002) 3.76
Local therapy and survival in breast cancer. N Engl J Med (2007) 3.33
Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res (2008) 3.25
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst (2012) 3.16
Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol (2002) 3.09
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer. J Clin Oncol (2008) 3.08
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res (2007) 3.08
Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol (2008) 3.04
End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol (2010) 2.97
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol (2013) 2.91
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res (2009) 2.90
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer (2008) 2.82
Brain metastases: the HER2 paradigm. Clin Cancer Res (2007) 2.81
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol (2004) 2.78
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst (2009) 2.77
Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med (2013) 2.76
Overall survival benefit with lapatinib in combination with trastuzumab for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: final results from the EGF104900 Study. J Clin Oncol (2012) 2.75
Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care (2005) 2.75
Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst (2002) 2.71
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63
Physicians' attitudes about multiplex tumor genomic testing. J Clin Oncol (2014) 2.62
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA (2012) 2.56
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. J Natl Cancer Inst (2008) 2.56
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol (2012) 2.53
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis. J Clin Oncol (2005) 2.52
The natural history of hormone receptor-positive breast cancer. Oncology (Williston Park) (2012) 2.50
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol (2005) 2.48
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer. J Clin Oncol (2012) 2.45
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. J Clin Oncol (2008) 2.43
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Effect of age on breast cancer outcomes in women with human epidermal growth factor receptor 2-positive breast cancer: results from a herceptin adjuvant trial. J Clin Oncol (2013) 2.35
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Do patients participating in clinical trials want to know study results? J Natl Cancer Inst (2003) 2.33
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy. J Clin Oncol (2011) 2.32
American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities. J Clin Oncol (2011) 2.30
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol (2006) 2.29
A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg (2006) 2.29
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst (2010) 2.28
Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol (2006) 2.24
Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care (2013) 2.22
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
HER2 testing in breast cancer: NCCN Task Force report and recommendations. J Natl Compr Canc Netw (2006) 2.15
Parents' views of cancer-directed therapy for children with no realistic chance for cure. J Clin Oncol (2008) 2.12
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst (2003) 2.11
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol (2005) 2.09
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. J Clin Oncol (2012) 2.07
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study. J Clin Oncol (2003) 1.96
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.94
Offering participants results of a clinical trial: sharing results of a negative study. Lancet (2005) 1.90